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Abstract 
 
Background: Yeonggyechulgam-tang (YGCGT) is a well-known classic herbal formula and has been used clinically 
in Korea for the treatment of chest congestion. High-performance liquid chromatography (HPLC) analytical method 
coupled with diode-array detection (DAD) was performed for the simultaneous analysis of eight bioactive components, 
liquiritin apioside, liquiritin, coumarin, liquiritigenin, cinnamic acid, cinnamaldehyde, glycyrrhizin, and atractylenolide 
III in a YGCGT decoction. 
Materials and Methods: For simultaneous analysis using HPLC, the eight components were separated using a 
Phenomenex Gemini C18 column (250 mm  4.6 mm; particle size 5 m) eluted with a gradient of 0.1% (v/v) aqueous 
trifluoroacetic acid and acetonitrile at 1.0 mL/min. The column temperature and injection volume were 40C and 10 L. 
Results: Correlation coefficients of the eight compounds ranged between 0.9996 and 1.0000. The lower limits of 
detection and quantification of the analytes were 0.01–0.09 and 0.02–0.28 g/mL, respectively. Recovery of the eight 
compounds was 97.63–102.70% and the relative standard deviation (RSD) was less than 3.00%. The RSDs of intra and 
interday precision were 0.06–2.07% and 0.02–1.95%, respectively. The amounts of the eight compounds in a 
lyophilized YGCGT were in the range 0.18 to 10.34 mg/g. 
Conclusion: The optimized and validated HPLC analytical method used in the present study is expected to be useful 
for evaluation the quality of YGCGT decoctions or related herbal prescriptions. 
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Introduction 
 
Traditional herbal formulas for the prevention and treatment of varied diseases have been of increasing 
interest globally, particularly in East Asian countries such as Korea, China, and Japan. The formulas are composed of 
two or more medicinal herbs, contain many bioactive ingredients, and can be applied to a variety of diseases (Liu et al., 
2008). Standardization of traditional herbal formulas is important. However, the standardization process is very 
difficult and requires considerable effort. Nevertheless, standardization is necessary to assure efficient quality control, 
coherent safety, efficacy, and stability of traditional herbal formulas (Li et al., 2008). Yeonggyechulgam-tang 
(YGCGT), known as Lingguizhugan-tang in Chinese and Ryokeijutsukanto in Japanese, is a well-known, classic herbal 
prescription consisting of four herbal medicines, including Poria Sclerotium (Polyporaceae), Cinnamomi Ramulus 
(Lauraceae), Atractylodis Rhizoma Alba (Compositae), and Glycyrrhizae Radix et Rhizoma (Leguminosae) in a ratio 
of 2:1.5:1.5:1, respectively, based on dry weight. It has been used clinically in Korea for the treatment of chest 
congestion (Heo, 2004). YGCGT has been reported to have a variety of biological effects and is useful for anti-
inflammation (Xi et al., 2012; Wang et al., 2015), renal failure (Park et al., 2000), liver protection (Kim et al., 1999), 
and chronic heart failure (Fu et al., 2010; Huang et al., 2013). An analytical method to determine cinnamic acid, a 
marker component of Cinnamomi Ramulus in decoctions of Lingguizhugan using a reversed phase high-performance 
liquid chromatography (RP–HPLC) method was reported by Huang et al (2002). However, this method is not sufficient 
to evaluate the quality of YGCGT using HPLC, because data for the separation and simultaneous determination of its 
various other components are not provided. Therefore, we achieved simultaneous analysis of multiple ingredients to 
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assess the quality of a YGCGT decoction using a HPLC analytical method that we validated and optimized in the 
present study. HPLC has become one of the most widely used techniques to analyze medicinal herbs and traditional 
herbal prescriptions (Li et al., 2005). Generally, it has the advantage that it can be applied to the analysis of almost all 
components with convenience, accuracy and precision (Waksmundzka-Hajnos and Sherma, 2010; Li et al., 2005). In 
this study, a HPLC analytical method coupled with diode-array detection (DAD) was established for the simultaneous 
analysis of eight bioactive ingredients: coumarin, cinnamic acid and cinnamaldehyde (from Cinnamomi Ramulus), 
atractylenolide III (from Atractylodis Rhizoma Alba), and liquiritin apioside, liquiritin, liquiritigenin, and glycyrrhizin 
(from Glycyrrhizae Radix et Rhizoma) in a YGCGT decoction. 
 
Materials and Methods 
Plant materials 
 
 Four raw herbal medicine components of YGCGT, Poria Sclerotium, Cinnamomi Ramulus, Atractylodis 
Rhizoma Alba, and Glycyrrhizae Radix et Rhizoma, were purchased from an herbal medicine market, Naemome Dah 
(Ulsan, Korea), and identified by a pharmacognosist, Prof. Jung-Hoon Kim, School of Korean Medicine, Pusan 
National University (Yangsan, Korea). Sample specimens (2012–KE48-1–KE48-4) have been deposited at the K-herb 
Research Center, Korea Institute of Oriental Medicine. 
 
Chemicals and reagents 
 
The reference standards, liquiritin (99.6%), liquiritigenin (99.8%), and glycyrrhizin (99.1%) were obtained 
from Biopurify Phytochemicals (Chengdu, China). Cinnamic acid (99.0%) and coumarin (99.0%) were bought from 
Merck (Darmstadt, Germany). Cinnamaldehyde (98.0%) was purchased from Wako Chemicals (Osaka, Japan), 
liquiritin apioside (98.0%) from Shanghai Sunny Biotech (Shanghai, China), and atractylenolide III (99.0%) from KOC 
Biotec (Daejeon, Korea). The structures of these standards are shown in Figure 1. Solvents such as methanol, 
acetonitrile, and water for HPLC analysis were HPLC grade and purchased from J.T. Baker (Phillipsburg, NJ, USA). 
Trifluoroacetic acid (TFA, analytical reagent grade) was obtained from Merck (Darmstadt, Germany). 
 
Apparatus and conditions 
 
HPLC system (Kyoto, Japan) consisting of two LC-20AT pumps, a DGU-20A3 online degasser, a CTO-20A 
forced air circulation type column oven, SIL-20A auto sample injector, and SPD-M20A DAD was used for the 
simultaneous analysis of the eight components in an extract of YGCGT. The detailed HPLC conditions in this study are 
shown in the Table 1. The DAD was in the range of 190–800 nm and for quantitative analysis the UV absorption of 
each analyte was monitored at 225 nm (atractylenolide III), 254 nm (glycyrrhizin), and 275 nm (liquiritin apioside, 
liquiritin, coumarin, liquiritigenin, cinnamic acid, and cinnamaldehyde). 
 
 
Figure 1: Chemical structures of eight bioactive compounds in Yeonggyechulgam-tang. 
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Preparation of reference standard solutions 
  
 Standard solutions of the eight compounds were prepared at a concentration of 1.0 mg/mL using methanol 
and stored at 4C before use. Each standard solution was diluted to give a series of working standard solutions. 
 
Preparation of YGCGT decoction and quality control sample 
 
The YGCGT decoction consisted of four medicinal herbs as listed in Table 2 (total weight = 5.0 kg, 
approximately 222 times the amount of a single dose), namely the raw material from the sclerotium of Poria cocos 
(1,667 g), ramulus of Cinnamomum cassia (1,250 g), rhizome of Atractylodes macrocephala (1,250 g), and root of 
Glycyrrhiza uralensis (833 g) were mixed and extracted in 50 L of water at 100C for 2 h. The extracted solution was 
lyophilized to give a powdered extract using a freeze dryer, PVT100 (IlShinBioBase, Yangju, Korea). The amount and 
yield of extracted YGCGT powder were 636.5 g and 12.7%, respectively. For quantitative analysis, 200 mg of freeze-
dried YGCGT powder was dissolved in 20 mL of 50% methanol and then extracted using an ultrasonicator for 30 min. 
The extracted solution was filtered using a 0.2 m membrane filter (PALL Life Sciences, Ann Arbor, MI, USA) before 
HPLC analysis. 
 
Table 1: HPLC parameters for analysis of marker compounds in Yeonggyechulgam-tang 
Operation conditions 
  HPLC system Shimadzu 
  Pump LC-20AT 
  Detector PDA (wavelength 225, 254, and 275 nm) 
  Column Gemini C18 (Phenomenex, 250 × 4.6 mm, 5m)  
  Column oven 40 ℃ 
  Flow rate 1.0 mL/min 
  Auto sampler SIL-20AC 
  Injection 10 L 
Mobile phase 
0.1% Trifluoroacetic acid in distilled water 
Acetonitrile (B) 
10–60% B for 0–30 min, 60–100% B for 30–40 min, 100% B for 40–45 min, 100–
10% B for 45–50 min, and 10% B for 50–60 min. 
 
Table 2: Composition of Yeonggyechulgam-tang. 
Latin name Scientific name Amount (g) Origin 
Poria Sclerotium Poria cocos Wolf 7.500 Pyeongchang, Korea 
Cinnamomi Ramulus Cinnamomum cassia Presl 5.625 Vietnam 
Atractylodis Rhizoma 
Alba 
Atractylodes macrocephala 
Koidzumi 
5.625 China 
Glycyrrhizae Radix et 
Rhizoma 
Glycyrrhiza uralensis Fischer 3.750 China 
Total 
 
22.500  
 
Calibration curves, lower limits of detection (LLOD), and of quantification (LLOQ) 
 
A regression equation using reference standard solutions was created by plotting the peak area (y) versus the 
corresponding concentration (x, g/mL) within the tested concentration ranges: liquiritin apioside and liquiritin (3.91–
250.00 g/mL), coumarin (1.56–100.00 g/mL), liquiritigenin, cinnamic acid, and atractylenolide III (0.78–50.00 
g/mL), cinnamaldehyde (4.69–150.00 g/mL), and glycyrrhizin (7.81–500.00 g/mL). Samples were measured in 
triplicate to prepare a regression equation. The LLOD and LLOQ values were calculated by analyzing the reference 
standard solution using signal-to-noise (S/N) ratios of approximately 3 and 10. 
 
Precision and recovery 
 
To test the precision of the established HPLC–DAD method, we conducted the intra- and interday tests using 
a standard addition method. This method was determined by addition of three different concentrations (low, middle, 
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and high) of an individual reference standard to the sample. Intra- and interday precision were assessed using the 
relative standard deviation (RSD) as an index. Reproducibility was evaluated by measuring the quality control sample 
in six replicates. The RSD values of the retention times and amount of the eight compounds were used to assess the 
reproducibility of the established analytical method. A recovery test was performed by spiking YGCGT samples with a 
known concentration (low, middle, and high) of reference standard. Lyophilized YGCGT sample (200 mg) was added 
to a 20 mL volumetric flask and each reference standard was added at three different concentrations. HPLC-grade 
water was added up to the volume mark. 
 
Results and Discussion 
Optimization of chromatographic conditions 
 
The accurate and precise HPLC method for simultaneous analysis of the eight bioactive ingredients, liquiritin 
apioside, liquiritin, coumarin, liquiritigenin, cinnamic acid, cinnamaldehyde, glycyrrhizin, and atractylenolide III was 
tested using HPLC conditions as follows: column types, including a Phenomenex Gemini C18 (250 mm × 4.6 mm, 5 
m), Waters SunFire C18 (250 mm  4.6 mm, 5 m), and Shiseido Capcell Pak UG120 C18 (250 mm  4.6 mm, 5 m), 
column temperatures (e.g., 30, 35, and 40C), several acidic mobile phases (e.g., acetic acid, formic acid and 
trifluoroacetic acid), and organic solvents (e.g., methanol and acetonitrile) to optimize baseline, resolution, and peak 
tailing chromatographic separation. We found optimal chromatographic conditions were obtained using a Gemini C18 
column (250 mm  4.6 mm, 5 m) eluted with a gradient of 0.1% (v/v) TFA in distilled water–acetonitrile at a column 
temperature of 40C. To determine the eight compounds in the YGCGT decoctions quantitatively, the UV absorption 
wavelength was set at 225 nm for atractylenolide III, 254 nm for glycyrrhizin, and 275 nm for liquiritin apioside, 
liquiritin, Coumarin, liquiritigenin, cinnamic acid, and cinnamaldehyde. Figure 2 shows the typical HPLC 
chromatograms of reference compounds and the YGCGT sample. 
 
System suitability 
 
The system suitability of the established HPLC–DAD method was examined using the following parameters: 
capacity (k), selectivity (), resolution (Rs), theoretical plate number (N), and tailing factor (Tf). The findings are 
shown in Table 3. 
 
Table 3: System suitability of the eight bioactive components 
Compound 
Capacity 
factor (k) 
Separation 
factor () 
Number of 
theoretical plates 
(N) 
Resolution 
(Rs) 
Tailing factor 
(Tf) 
Liquiritin apioside 3.72 1.03 39811 0.97 1.06 
Liquiritin 3.81 1.36 38421 0.97 1.02 
Coumarin 5.18 1.11 20681 3.65 0.97 
Liquiritigenin 5.77 1.06 30910 2.08 0.96 
Cinnamic acid 6.10 1.10 32403 2.08 0.96 
Cinnamaldehyde 6.70 1.17 25589 3.44 1.12 
Glycyrrhizin 7.83 1.17 39006 6.06 1.08 
Atractylenolide III 9.16 1.17 72583 8.09 0.95 
 
Linearity, range, sensitivity, LLOD, and LLOQ 
 
The linearity of the calibration curve was determined using correlation coefficients (r
2
). The r
2
 of the eight 
reference standards determined using this method ranged between 0.9996 and 1.0000. These findings suggest that the 
linearity is very good in the seven concentration ranges tested. The LLOD and LLOQ of the all analytes were 0.01–
0.09 and 0.02–0.28 g/mL, respectively, indicating good sensitivity for this analytical method. These data are 
summarized in Table 4. 
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Figure 2: HPLC chromatograms of a mixture of reference standards (A) and a Yeonggyechulgam-tang sample (B) at 
225 nm (I), 254 nm (II), and 275 nm (III). 1: Liquiritin apioside, 2: liquiritin, 3: coumarin, 4: liquiritigenin, 5: cinnamic 
acid, 6: cinnamaldehyde, 7: glycyrrhizin, 8: atractylenolide III 
 
Table 4: Linear range, regression equations, correlation coefficients, LLODs, and LLOQs of the eight bioactive 
compounds 
Compound 
Linear range 
(g/mL) 
Regression 
equation
a
 
Correlation 
coefficient 
LLOD
b
 
(g/mL) 
LLOQ
c
 
(g/mL) 
Liquiritin apioside 3.91–250.00 
y = 15976.77x – 
19465.49 
0.9999 0.05 0.15 
Liquiritin 3.91–250.00 
y = 22314.06x – 
3236.49 
1.0000 0.04 0.11 
Coumarin 1.56–100.00 
y = 59702.66x – 
29138.58 
1.0000 0.01 0.04 
Liquiritigenin 0.78–50.00 
y = 34088.68x – 
2776.29 
1.0000 0.02 0.07 
Cinnamic acid 0.78–50.00 
y = 98964.19x – 
12325.07 
1.0000 0.01 0.02 
Cinnamaldehyde 4.69–150.00 
y = 138103.61x + 
105800.30 
0.9996 0.01 0.02 
Glycyrrhizin 7.81–500.00 
y = 8474.17x – 
20042.01 
0.9999 0.09 0.28 
Atractylenolide III 0.78–50.00 
y = 23958.43x – 
3736.71 
1.0000 0.04 0.12 
a
y: peak area (mAU) of compounds; x: concentration (g/mL) of compounds; bLLOD = 3  signal-to-noise ratio. 
c
LLOQ = 10  signal-to-noise ratio. 
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Recovery and precision 
 
Recovery of the eight compounds from the YGCGT decoction was 97.63–102.70% and the RSD value was 
less than 3.00% (Table 5). Reproducibility of the optimized HPLC–DAD method was determined by the RSD as the 
amount of each analyte and retention time. RSD to assess reproducibility were 0.10–1.45% of the amounts of the eight 
compounds and 0.06–0.73% for their retention times (Table 6). The RSD of the assay for intra- and interday precision 
of the present method were 0.06–2.07% and 0.02–1.95%, respectively (Table 7). Therefore, the present analytical 
method was considered to be sufficiently accurate and precise for the simultaneous quantification of the eight bioactive 
compounds in YGCGT decoctions. 
 
Table 5: Recovery test for the assay of eight compounds in Yeonggyechulgam-tang 
Compound 
Original 
conc. 
(g/mL) 
Spiked conc. 
(g/mL) 
Found conc. 
(g/mL) 
Recovery
a
 
(%) 
SD 
RSD 
(%) 
Liquiritin apioside 48.97  
10.00  59.24  102.62 1.23 1.20 
25.00  74.45  101.52 1.59 1.57 
50.00  99.55  101.16 0.61 0.60 
Liquiritin 50.22  
10.00  60.11  98.83 1.80 1.82 
25.00  75.90  102.70 2.87 2.79 
50.00  100.98  101.51 0.29 0.28 
Coumarin 30.95  
6.00  36.95  100.03 0.79 0.79 
15.00  46.15  101.38 0.71 0.70 
30.00  61.03  100.28 1.18 1.17 
Liquiritigenin 6.22  
1.00  7.23  100.77 1.08 1.08 
2.00  8.23  100.39 1.39 1.38 
5.00  11.28  101.07 0.92 0.91 
Cinnamic acid 5.83  
1.00  6.85 101.28 0.45 0.44 
2.00  7.86 101.41 0.43 0.43 
5.00  10.88 100.83 0.30 0.29 
Cinnamaldehyde 69.63  
12.00  81.50 98.84 1.15 1.16 
30.00  99.39 99.18 0.79 0.80 
60.00  129.34 99.51 0.88 0.88 
Glycyrrhizin 100.88  
20.00  120.64 98.82 1.49 1.51 
50.00  151.71 101.66 1.40 1.38 
100.00  201.09 100.21 0.35 0.35 
Atractylenolide III 2.17  
1.00  3.14 97.63 1.01 1.04 
2.00  4.15 99.21 1.56 1.57 
4.00  6.20 100.92 0.72 0.71 
a
Recovery (%) = (Found conc. – Original conc.)/Spiked conc.  100. 
 
Table 6: Reproducibility of retention times and amount of the eight compounds (n = 6) 
Compound 
Retention time (min) Amount (g/mL) 
Mean  SD RSD (%) Mean ± SD RSD (%) 
Liquiritin apioside 14.26  0.10 0.73 48.47  0.52 1.07 
Liquiritin 14.55  0.09 0.60 49.71  0.14 0.27 
Coumarin 18.77  0.01 0.07 30.72  0.41 1.33 
Liquiritigenin 20.58  0.02 0.11 6.15  0.09 1.45 
Cinnamic acid 21.59  0.02 0.08 5.83  0.03 0.46 
Cinnamaldehyde 23.42  0.01 0.06 69.02  0.29 0.42 
Glycyrrhizin 26.84  0.02 0.07 100.88  0.11 0.10 
Atractylenolide III 30.84  0.03 0.09 2.17  0.01 0.44 
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Table 7: Precision assay for eight compounds in Yeonggyechulgam-tang 
Compound 
Spiked 
conc. 
(g/mL) 
Intraday (n = 5) Interday (n = 5) 
Observed 
conc. 
(g/mL) 
Precision
a
 
(%) 
Accuracy 
(%) 
Observed 
conc. 
(g/mL) 
Precision 
(%) 
Accuracy 
(%) 
Liquiritin 
apioside 
10.00  10.06 1.64 100.55 9.86 0.83 98.64 
25.00  25.10 2.07 100.41 25.15 0.95 100.60 
50.00  49.94 0.46 99.87 49.95 0.22 99.90 
Liquiritin 
10.00  9.76 1.71 97.62 10.10 0.59 100.99 
25.00  25.27 2.03 101.09 24.97 1.30 99.89 
50.00  49.91 0.46 99.82 49.99 0.31 99.99 
Coumarin 
6.00  5.95 0.50 99.23 6.06 0.61 101.05 
15.00  15.13 1.24 100.84 15.07 0.61 100.48 
30.00  29.95 0.30 99.82 29.95 0.14 99.84 
Liquiritigenin 
1.00  1.00 0.65 100.14 1.01 1.49 100.94 
2.00  1.99 0.93 99.54 1.97 1.43 98.30 
5.00  5.00 0.15 100.07 5.01 0.19 100.23 
Cinnamic acid 
1.00  1.00 0.40 100.01 0.99 1.21 99.12 
2.00  2.01 0.44 100.38 2.00 1.12 99.92 
5.00  5.00 0.06 99.94 5.00 0.14 100.05 
Cinnamaldehy
de 
12.00  11.97 0.77 99.74 12.04 1.95 100.31 
30.00  29.95 0.74 99.82 29.64 1.18 98.81 
60.00  60.03 0.20 100.06 59.69 1.57 99.48 
Glycyrrhizin 
20.00  19.66 0.99 98.29 19.84 1.31 99.20 
50.00  50.59 0.82 101.19 50.54 0.27 101.09 
100.00  99.77 0.19 99.77 99.76 0.02 99.76 
Atractylenolid
e III 
1.00  0.99 0.71 98.54 0.99 0.37 99.43 
2.00  1.98 1.04 99.11 1.96 0.90 98.05 
4.00  4.01 0.23 100.31 4.02 0.20 100.52 
a
Precision is expressed as RSD (%) = (SD/mean)  100. 
 
Quantification of the bioactive compounds in YGCGT decoctions 
 
The amounts of the eight compounds in the lyophilized YGCGT decoction were in the range 0.18 to 10.34 
mg/g (Table 8). 
 
Conclusion 
 
A HPLC–DAD analytical method for the quantitative analysis of eight bioactive compound components of 
YGCGT decoctions was successfully established and validated, for the first time to our knowledge. We simultaneously 
determined eight compounds in a YGCGT decoction by using HPLC–DAD; namely, coumarin, cinnamic acid, and 
cinnamaldehyde (from Cinnamomi Ramulus), atractylenolide III (from Atractylodis Rhizoma Alba), and liquiritin 
apioside, liquiritin, liquiritigenin, and glycyrrhizin (from Glycyrrhizae Radix et Rhizoma). These eight compounds 
were eluted within 35 min a HPLC–DAD analytical method established and validated in the present study with a 
resolution of 0.97. The retention times of the eight analytes were approximately 14.26, 14.55, 18.77, 20.58, 21.57, 
23.42, 26.84, and 30.84 min, respectively. Tests showed good linearity with an r
2
 of 0.9996, reproducibility, recovery, 
and precision. Glycyrrhizin, which is a bioactive component of Glycyrrhizae Radix et Rhizoma, was determined as the 
most abundant bioactive compound in a YGCGT decoction. This method is expected to aid the quality control of 
YGCGT decoctions or related herbal prescriptions. 
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Table 8: The amount of eight bioactive compounds in the Yeonggyechulgam-tang (n = 3) 
Compound 
Batch (No.) 
Concentrations (mg/g)  SD ( 10–2) 
1 2 3 
Liquiritin apioside 4.81  0.51 4.80  0.63 4.76  0.31 
Liquiritin 4.90  0.11 4.91  0.74 4.86  1.22 
Coumarin 3.01  0.74 3.12  1.32 3.04  4.85 
Liquiritigenin 0.54  0.82 0.54  0.22 0.57  0.80 
Cinnamic acid 0.58  0.24 0.57  0.04 0.57  0.24 
Cinnamaldehyde 6.84  2.02 6.80  2.07 6.79  4.96 
Glycyrrhizin 10.34  0.91 10.30  1.02 10.20  2.31 
Atractylenolide III 0.18  0.06 0.18  0.05 0.19  0.06 
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